BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

262 related articles for article (PubMed ID: 15212767)

  • 1. Lack of cytotoxic property in a variant of Epstein-Barr virus latent membrane protein-1 isolated from nasopharyngeal carcinoma.
    Nitta T; Chiba A; Yamamoto N; Yamaoka S
    Cell Signal; 2004 Sep; 16(9):1071-81. PubMed ID: 15212767
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The transmembrane domains of the EBV-encoded latent membrane protein 1 (LMP1) variant CAO regulate enhanced signalling activity.
    Blake SM; Eliopoulos AG; Dawson CW; Young LS
    Virology; 2001 Apr; 282(2):278-87. PubMed ID: 11289810
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The NPC derived C15 LMP1 protein confers enhanced activation of NF-kappa B and induction of the EGFR in epithelial cells.
    Miller WE; Cheshire JL; Baldwin AS; Raab-Traub N
    Oncogene; 1998 Apr; 16(14):1869-77. PubMed ID: 9583684
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of functional differences between prototype Epstein-Barr virus-encoded LMP1 and a nasopharyngeal carcinoma-derived LMP1 in human epithelial cells.
    Dawson CW; Eliopoulos AG; Blake SM; Barker R; Young LS
    Virology; 2000 Jun; 272(1):204-17. PubMed ID: 10873763
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A novel dominant-negative mutant form of Epstein-Barr virus latent membrane protein-1 (LMP1) selectively and differentially impairs LMP1 and TNF signaling pathways.
    Adriaenssens E; Mougel A; Goormachtigh G; Loing E; Fafeur V; Auriault C; Coll J
    Oncogene; 2004 Apr; 23(15):2681-93. PubMed ID: 14767477
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activation of the cJun N-terminal kinase (JNK) pathway by the Epstein-Barr virus-encoded latent membrane protein 1 (LMP1).
    Eliopoulos AG; Young LS
    Oncogene; 1998 Apr; 16(13):1731-42. PubMed ID: 9582021
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epstein-Barr virus (EBV) latent membrane protein 1 induces interleukin-8 through the nuclear factor-kappa B signaling pathway in EBV-infected nasopharyngeal carcinoma cell line.
    Ren Q; Sato H; Murono S; Furukawa M; Yoshizaki T
    Laryngoscope; 2004 May; 114(5):855-9. PubMed ID: 15126743
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epstein-Barr virus latent membrane protein 1 (LMP1) upregulates Id1 expression in nasopharyngeal epithelial cells.
    Li HM; Zhuang ZH; Wang Q; Pang JC; Wang XH; Wong HL; Feng HC; Jin DY; Ling MT; Wong YC; Eliopoulos AG; Young LS; Huang DP; Tsao SW
    Oncogene; 2004 May; 23(25):4488-94. PubMed ID: 15064751
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differences in the immunogenicity of latent membrane protein 1 (LMP1) encoded by Epstein-Barr virus genomes derived from LMP1-positive and -negative nasopharyngeal carcinoma.
    Hu L; Troyanovsky B; Zhang X; Trivedi P; Ernberg I; Klein G
    Cancer Res; 2000 Oct; 60(19):5589-93. PubMed ID: 11034108
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Epstein-Barr virus latent membrane protein-1 (LMP1) mediates activation of NF-kappa B and cell surface phenotype via two effector regions in its carboxy-terminal cytoplasmic domain.
    Huen DS; Henderson SA; Croom-Carter D; Rowe M
    Oncogene; 1995 Feb; 10(3):549-60. PubMed ID: 7845680
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epstein-Barr virus latent membrane protein 1 modulates epidermal growth factor receptor promoter activity in a nuclear factor kappa B-dependent manner.
    Tao YG; Tan YN; Liu YP; Song X; Zeng L; Gu HH; Tang M; Li W; Yi W; Cao Y
    Cell Signal; 2004 Jul; 16(7):781-90. PubMed ID: 15115657
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Effects of two LMP1 variants on resistance of CNE1 cell strain to TGF-beta1].
    Huang H; Huang PC
    Ai Zheng; 2003 Dec; 22(12):1254-9. PubMed ID: 14693046
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The latent membrane protein 1 (LMP1) encoded by Epstein-Barr virus induces expression of the putative oncogene Bcl-3 through activation of the nuclear factor-kappaB.
    Nakamura H; Ishii C; Suehiro M; Iguchi A; Kuroda K; Shimizu K; Shimizu N; Imadome K; Yajima M; Fujiwara S
    Virus Res; 2008 Feb; 131(2):170-9. PubMed ID: 17963943
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The cytoplasmic amino-terminus of the Latent Membrane Protein-1 of Epstein-Barr Virus: relationship between transmembrane orientation and effector functions of the carboxy-terminus and transmembrane domain.
    Coffin WF; Erickson KD; Hoedt-Miller M; Martin JM
    Oncogene; 2001 Aug; 20(38):5313-30. PubMed ID: 11536044
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of the LMP1 oncoprotein in the EBV negative Hodgkin's disease cell line L-428 is associated with Reed-Sternberg cell morphology.
    Knecht H; McQuain C; Martin J; Rothenberger S; Drexler HG; Berger C; Bachmann E; Kittler EL; Odermatt BF; Quesenberry PJ
    Oncogene; 1996 Sep; 13(5):947-53. PubMed ID: 8806684
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Endogenous latent membrane protein 1 in Epstein-Barr virus-infected nasopharyngeal carcinoma cells attracts T lymphocytes through upregulation of multiple chemokines.
    Lai HC; Hsiao JR; Chen CW; Wu SY; Lee CH; Su IJ; Takada K; Chang Y
    Virology; 2010 Sep; 405(2):464-73. PubMed ID: 20637487
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epstein-Barr virus-encoded LMP1 promotes cisplatin-induced caspase activation through JNK and NF-kappaB signaling pathways.
    Zhang X; Sanmun D; Hu L; Fadeel B; Ernberg I
    Biochem Biophys Res Commun; 2007 Aug; 360(1):263-8. PubMed ID: 17586463
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Upregulated expression of kappa light chain by Epstein-Barr virus encoded latent membrane protein 1 in nasopharyngeal carcinoma cells via NF-kappaB and AP-1 pathways.
    Liu HD; Zheng H; Li M; Hu DS; Tang M; Cao Y
    Cell Signal; 2007 Feb; 19(2):419-27. PubMed ID: 16979873
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of Epstein-Barr virus encoded latent membrane protein 1 in the carcinogenesis of nasopharyngeal carcinoma.
    Zheng H; Li LL; Hu DS; Deng XY; Cao Y
    Cell Mol Immunol; 2007 Jun; 4(3):185-96. PubMed ID: 17601372
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transcriptional activation of NF-kappa B activity by Epstein-Barr virus (EBV) LMP1 as a selective therapeutic strategy for EBV-associated diseases.
    Wu CJ; Leu CY; Liu ST; Chow KP; Meng CL; Chang YS
    Gene Ther; 1998 Jul; 5(7):905-12. PubMed ID: 9813661
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.